Q1 2025 Management View CEO Ryan Spencer announced that Q1 2025 was the company’s strongest first quarter for HEPLISAV-B, ...

Q1 2025 Management View CEO Bom Kim highlighted an 11% year-over-year revenue growth in Q1 2025, or 21% on a constant ...

Growth drivers were sales for glasses with progressive lenses, and contact lenses, which both have hefty profit margins ...

An unnamed tenant has decided not to renew its lease with real estate investment trust (REIT) LTC Properties (NYSE: LTC) for seven skilled nursing ...